Chlorhexidine Gluconate Oral Rinse
Subpotent Drug: Product crystallization with accompanying low out of specification results for chlorhexidine assay.
Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk.
992 FDA drug recalls with this cause, newest first.
These recalls cover sub-potent or super-potent products, or a failed content-uniformity test - meaning some pills in the same batch held noticeably different amounts of active ingredient than others. Either way it is a direct dosing risk: too little to work, or too much and harmful. Thyroid hormones and compounded injectables are the classic examples, because their dose window is narrow.
Subpotent Drug: Product crystallization with accompanying low out of specification results for chlorhexidine assay.
Superpotent Drug
Superpotent Drug: High out of specification results for tazarotene assay at the 9-month stability time point.
Subpotent Drug: The product has failed to maintain its label claim of coal tar throughout its labeled 24-month expiry period.
Superpotent and Failed Stability Specifications; out of specification results for assay and water vapor permeability
Subpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet.
Subpotent Drug: product not meeting the iodine assay level requirements through the labeled expiry.
Subpotent Drug: Out of specification for an active ingredient cysteamine hydrochloride.
Subpotent Drug: Out of specification for assay (stability testing)
Superpotent drug: failed assay throughout the stick after 6 months stability.
Subpotent Drug: The product is sub-potent prior to its 90-day beyond use date.
Failed Content Uniformity Specifications
Subpotent Drug
Subpotent Drug
Subpotent Drug: One lot of Viokace is being recalled since product stability testing results did not meet the specifications for enzyme profile.
Superpotent
Superpotent
Subpotent Drug
SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent
SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent
Superpotent drug: out of specification result for potency
Subpotent Drug: The laminate used to make the pouches was reversed such that the aluminum layer was in contact with the product causing an exothermic reaction between the free iodine and the aluminum.
Superpotent Drug
Subpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.